Skip to main content
NCBI home page
Molecular Genetics & Genomic Medicine logoLink to Molecular Genetics & Genomic Medicine
. 2019 Mar 9;7(4):e00538. doi: 10.1002/mgg3.538

Correlation between MTHFR polymorphisms and glaucoma: A meta‐analysis

Ling Zhang 1, Bin Chen 1,✉
PMCID: PMC6465672  PMID: 30851082

Abstract

Background

Whether methylenetetrahydrofolate reductase (MTHFR) polymorphisms are implicated in glaucoma remains controversial. Therefore, we performed this study to better assess the relationship between MTHFR polymorphisms and the likelihood of glaucoma.

Methods

A systematic research of PubMed, Medline, and Embase was performed to retrieve relevant articles. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated.

Results

A total of 18 studies with 7,168 participants were analyzed. In overall analyses, a significant association with the likelihood of glaucoma was detected for the rs1801133 polymorphism in dominant (p = 0.04, OR = 0.90, 95%CI 0.81–1.00) and allele (p = 0.02, OR = 0.91, 95%CI 0.84–0.98) comparisons. Further, subgroup analyses by ethnicity revealed that both rs1801131 and rs1801133 polymorphisms were significantly associated with the likelihood of glaucoma in West Asians. However, no positive results were detected for two investigated polymorphisms in East Asians and Caucasians.

Conclusion

Our findings indicated that rs1801131 and rs1801133 polymorphisms may serve as genetic biomarkers of glaucoma in West Asians.

Keywords: gene polymorphisms, glaucoma, meta‐analysis, methylenetetrahydrofolate reductase (MTHFR)

1. INTRODUCTION

Glaucoma, characterized by atrophy of optic nerve and progressive loss of sight, is one of the leading causes of blindness all over the world (Mantravadi & Vadhar, 2015). Over the past two decades, the prevalence of glaucoma has significantly increased, and according to an epidemiological study, it is estimated that glaucoma would affect over 80 million people by 2020 (Weinreb, Aung, & Medeiros, 2014). So far, the exact cause of glaucoma is still largely unclear. Nevertheless, the fact that multiple genetic loci have found to be correlated with individual susceptibility to this disease suggested that genetic factors play crucial roles in the occurrence and development of glaucoma (Asefa, Neustaeter, Jansonius, & Snieder, 2018; Cissé, Bai, & Meng, 2018; Wiggs & Pasquale, 2017).

Methylenetetrahydrofolate reductase (MTHFR) is a central regulator of folate metabolism and homocysteine synthesis (Trimmer, 2013). Previous studies have demonstrated that MTHFR deficiency could lead to hyperhomocysteinemia and give rise to the development of multiple vascular and neurodegenerative disorders including glaucoma (Li, Xu, Zeng, Gong, & Lan, 2016; Zacharaki et al., 2014). As a result, functional MTHFR (NG_013351.1) polymorphisms are thought to be ideal candidate genetic biomarkers of glaucoma.

Until now, some pilot studies have investigated possible correlations of MTHFR rs1801131 (A1298C) and rs1801133 (C677T) polymorphisms with glaucoma, but the results of these studies were conflicting and the sample size of individual studies was relatively small (Al‐Shahrani et al., 2016; Buentello‐Volante et al., 2013; Gupta et al., 2014; Nilforoushan et al., 2012). Therefore, we performed the present meta‐analysis to better elucidate the relation between MTHFR polymorphisms and glaucoma.

2. MATERIALS AND METHODS

2.1. Ethical compliance

This article does not contain any studies with human participants or animals performed by any of the authors, so ethical approval is not required.

2.2. Literature search and inclusion criteria

The current meta‐analysis was adhered to the Preferred Reporting Items for Systematic Reviews and Meta‐analyses (PRISMA) guideline (Moher, Liberati, Tetzlaff, Altman, & PRISMA group., 2009). PubMed, Medline, and Embase were searched for relative articles published before September 2018 using the following strategy: (methylenetetrahydrofolate reductase OR MTHFR) AND (polymorphism OR variant OR mutation OR genotype OR allele) AND (primary open‐angle glaucoma OR POAG OR primary closed angle glaucoma OR PCAG OR pseudoexfoliation glaucoma OR PXFG OR glaucoma). The reference lists of all retrieved publications were also manually screened to identify other potentially relevant articles.

To test the research hypothesis of this meta‐analysis, included studies should meet all the following criteria: (a) case–control study on correlation between MTHFR polymorphisms and the likelihood of glaucoma; (b) provide adequate data to calculate odds ratios (ORs) and 95% confidence intervals (CIs); (c) full text in English or Chinese available. Studies were excluded if one of the following criteria was fulfilled: (a) not relevant to MTHFR polymorphisms and glaucoma; (b) family‐based association studies; (c) case reports or case series; (d) abstracts, reviews, comments, letters, and conference presentations. For duplicate reports, we only included the study with the largest sample size for analyses.

2.3. Data extraction and quality assessment

The following data were extracted from all included studies: (a) name of first author; (b) year of publication; (c) country and ethnicity of participants; (d) the number of cases and controls; and (e) the genotypic distribution of MTHFR polymorphisms in cases and controls. Additionally, the probability value (p value) of Hardy–Weinberg equilibrium (HWE) was also calculated. The Newcastle‐Ottawa scale (NOS) was used to assess the quality of eligible studies (Stang, 2010). The NOS has a score range of zero to nine, and studies with a score of more than seven were thought to be of high quality. Two reviewers conducted data extraction and quality assessment independently. When necessary, the reviewers wrote to the corresponding authors for extra information or raw data. Any disagreement between two reviewers was solved by discussion until a consensus was reached.

2.4. Statistical analysis

All statistical analyses were conducted with Review Manager Version 5.3.3 (The Cochrane Collaboration, Software Update, Oxford, United Kingdom). ORs and 95% CIs were calculated to assess potential associations of MTHFR polymorphisms with the likelihood of glaucoma in all possible genetic models, and a p value of 0.05 or less was considered to be statistically significant. Between‐study heterogeneities were evaluated with I 2 statistic. If I 2 was greater than 50%, random‐effect models (REMs) would be used to pool the data in overall and subgroup analyses. Otherwise, fixed‐effect models (FEMs) would be employed for synthetic analyses. Sensitivity analyses were carried out to test the stability of our findings. Funnel plots were applied to evaluate possible publication bias.

3. RESULTS

3.1. Characteristics of included studies

The literature search generated 144 results. After exclusion of irrelevant and duplicate articles by reading titles and abstracts, 30 articles were retrieved for further evaluation. Another 12 articles were subsequently excluded after reading the full text. Finally, a total of 18 eligible studies containing 3,453 cases and 3,715 controls were included for analyses (see Figure 1). Characteristics of included studies were summarized in Table 1.

Figure 1.

Figure 1

Open in a new tab

Flowchart of study selection for the present study

Table 1.

The characteristics of included studies

First author, year Country Ethnicity Type of disease Sample size Genotype distribution p‐value for HWE NOS score
Cases Controls
rs1801131
Fan, 2008 USA Mixed PXFG 158/50 74/58/26 22/19/9 0.191 7
Mabuchi, 2006 Japan East Asian POAG 264/106 167/94/3 61/44/1 0.023 7
Micheal, 2009 Pakistan West Asian POAG 173/143 35/114/24 20/97/26 <0.001 7
Micheal, 2009 Pakistan West Asian PCAG 122/143 34/76/12 20/97/26 <0.001 7
Woo, 2009 Korea East Asian POAG 78/100 57/19/2 75/22/3 0.388 8
Zacharaki, 2014 Greece Caucasian POAG 66/133 33/27/6 64/56/13 0.883 8
Zacharaki, 2014 Greece Caucasian PXFG 74/133 31/32/11 64/56/13 0.883 8
Zetterberg, 2007 Sweden Caucasian POAG 243/187 119/97/27 88/87/12 0.117 7
rs1801133
Al‐Shahrani, 2016 Saudi Arabia West Asian POAG 144/280 88/56/0 210/70/0 0.017 8
Al‐Shahrani, 2016 Saudi Arabia West Asian PCAG 66/280 49/17/0 210/70/0 0.017 8
Bleich, 2002 Germany Caucasian POAG 18/19 5/11/2 13/5/1 0.588 7
Buentello‐Volante, 2013 Mexico Mixed POAG 118/100 42/53/23 34/49/17 0.927 7
Clement, 2009 Australia Caucasian POAG 70/42 38/25/7 25/14/3 0.598 8
Clement, 2009 Australia Caucasian PXFG 48/42 18/23/7 25/14/3 0.598 8
Fan, 2008 USA Mixed PXFG 168/50 66/82/20 21/22/7 0.750 7
Fan, 2010 China East Asian POAG 397/201 244/137/16 135/60/6 0.830 7
Fingert, 2006 USA Mixed POAG 178/166 72/77/29 75/73/18 0.970 7
Fingert, 2006 USA Mixed PXFG 45/166 12/29/4 75/73/18 0.970 7
Gupta, 2014 India West Asian POAG 144/173 101/35/8 137/34/2 0.946 8
Gupta, 2014 India West Asian PCAG 87/173 73/14/0 137/34/2 0.946 8
Jünemann, 2005 Germany Caucasian POAG 76/71 32/37/7 45/24/2 0.569 7
Jünemann, 2005 Germany Caucasian PXFG 71/71 36/29/6 45/24/2 0.569 7
Mabuchi, 2006 Japan East Asian POAG 264/106 105/113/46 48/39/19 0.035 7
Micheal, 2009 Pakistan West Asian POAG 173/143 123/49/1 101/41/1 0.144 7
Micheal, 2009 Pakistan West Asian PCAG 122/143 84/26/12 101/41/1 0.144 7
Mossbock, 2006 Austria Caucasian POAG 204/211 119/71/14 105/86/20 0.696 7
Mossbock, 2006 Austria Caucasian PXFG 138/211 72/50/16 105/86/20 0.696 7
Nilforoushan, 2012 Iran West Asian POAG 73/90 39/28/6 53/33/4 0.688 8
Nilforoushan, 2012 Iran West Asian PXFG 85/90 46/31/8 53/33/4 0.688 8
Shi, 2013 China East Asian PCAG 231/306 81/106/44 93/152/61 0.938 8
Turaçli, 2005 Turkey Caucasian PXFG 76/34 39/31/6 18/12/4 0.382 7
Woo, 2009 Korea East Asian POAG 78/100 25/34/19 31/50/19 0.884 8
Zacharaki, 2014 Greece Caucasian POAG 64/130 22/31/11 39/70/21 0.264 8
Zacharaki, 2014 Greece Caucasian PXFG 72/130 29/33/10 39/70/21 0.264 8
Zetterberg, 2007 Sweden Caucasian POAG 243/187 126/97/20 89/75/23 0.252 7
Open in a new tab

HWE, Hardy–Weinberg equilibrium; NA, Not available; NOS, Newcastle‐Ottawa scale; PCAG, Primary closed angle glaucoma; POAG, Primary open‐angle glaucoma; PXFG, Pseudoexfoliation glaucoma.

3.2. Overall and subgroup analyses

A total of 18 studies with 7,168 participants were analyzed. In overall analyses, a significant association with the likelihood of glaucoma was detected for the rs1801133 polymorphism in dominant (p = 0.04, OR = 0.90, 95%CI 0.81–1.00) and allele (p = 0.02, OR = 0.91, 95%CI 0.84–0.98) comparisons. Further subgroup analyses by ethnicity revealed that both rs1801131 and rs1801133 polymorphisms were significantly associated with the likelihood of glaucoma in West Asians. However, no positive results were detected for two investigated polymorphisms in East Asians and Caucasians. When we stratified data based on type of disease, we found that the rs1801133 polymorphism was also significantly associated with the likelihood of primary open‐angle glaucoma (POAG). No any other positive findings were observed in overall and subgroup analyses (see Table 2 and Data S1).

Table 2.

Results of overall and subgroup analyses for MTHFR polymorphisms and glaucoma

Population Sample size Dominant comparison Recessive comparison Additive comparison Allele comparison
P value OR (95%CI) I 2 statistic P value OR (95%CI) I 2 statistic P value OR (95%CI) I 2 statistic P value OR (95%CI) I 2 statistic
rs1801131 A/C
Overall 1178/995 0.71 0.95 (0.70–1.27) 19% 0.07 1.19 (0.98–1.44) 21% 0.13 0.87 (0.72–1.04) 0% 0.15 0.91 (0.79–1.04) 20%
East Asian 342/206 0.97 0.98 (0.24–3.96) 0% 0.50 1.14 (0.78–1.67) 0% 0.50 0.88 (0.60–1.29) 0% 0.55 0.91 (0.65–1.25) 0%
West Asian 295/286 0.04 0.62 (0.39–0.98) 0% 0.003 1.91 (1.24–2.94) 0% 0.36 0.85 (0.60–1.20) 0% 0.007 0.72 (0.58–0.92) 0%
Caucasian 383/453 0.09 1.51 (0.94–2.42) 0% 0.99 1.00 (0.75–1.32) 0% 0.32 0.87 (0.65–1.15) 0% 0.43 1.09 (0.88–1.35) 0%
POAG 824/669 0.80 1.05 (0.71–1.56) 0% 0.20 1.16 (0.93–1.46) 20% 0.16 0.86 (0.69–1.07) 0% 0.40 0.93 (0.79–1.10) 0%
PXFG 232/183 0.57 1.19 (0.65–2.18) 0% 0.68 0.92 (0.60–1.40) 0% 0.99 1.00 (0.65–1.55) 0% 0.55 1.10 (0.81–1.52) 15%
rs1801133 C/T
Overall 3453/3715 0.04 0.90 (0.81–1.00) 43% 0.08 1.16 (0.98–1.38) 9% 0.30 1.06 (0.95–1.17) 28% 0.02 0.91 (0.84–0.98) 45%
East Asian 970/713 0.58 0.94 (0.76–1.16) 22% 0.74 1.05 (0.78–1.42) 0% 0.76 1.03 (0.84–1.27) 22% 0.57 0.96 (0.82–1.11) 0%
West Asian 894/1372 0.02 0.80 (0.66–0.97) 20% <0.001 3.07 (1.64–5.76) 18% 0.29 1.11 (0.91–1.35) 36% 0.002 0.77 (0.65–0.91) 25%
Caucasian 1080/1148 0.40 0.88 (0.65–1.18) 61% 0.94 1.01 (0.76–1.34) 0% 0.99 1.00 (0.84–1.19) 32% 0.34 0.90 (0.71–1.13) 62%
POAG 2244/2019 0.02 0.86 (0.76–0.98) 50% 0.19 1.16 (0.93–1.46) 2% 0.13 1.10 (0.97–1.26) 33% 0.04 0.85 (0.73–1.00) 53%
PCAG 506/902 0.35 1.13 (0.88–1.45) 0% 0.54 1.87 (0.25–13.87) 74% 0.15 0.84 (0.65–1.07) 0% 0.76 1.03 (0.85–1.25) 34%
PXFG 703/794 0.16 0.85 (0.69–1.06) 44% 0.45 1.15 (0.80–1.64) 0% 0.34 1.11 (0.89–1.39) 31% 0.15 0.89 (0.75–1.05) 33%
Open in a new tab

CI, Confidence interval; NA, Not available; OR, Odds ratio; POAG, Primary open‐angle glaucoma; PCAG, Primary closed angle glaucoma; PXFG, Pseudoexfoliation glaucoma.

MTHFR, NCBI Reference Sequence: NG_013351.1

The values in bold represent there are statistically significant differences between cases and controls.

3.3. Sensitivity analyses

Sensitivity analyses were conducted to examine the stability of synthetic results by eliminating studies that deviated from HWE. No changes of results were found in any comparisons, which indicated that our findings were statistically reliable.

3.4. Publication biases

Potential publication biases in the current study were evaluated with funnel plots. No obvious asymmetry of funnel plots was observed in any comparisons, which suggested that our findings were unlikely to be influenced by severe publication bias.

4. DISCUSSION

To the best of our knowledge, this is so far the most comprehensive meta‐analysis on correlations between MTHFR polymorphisms and glaucoma. The overall and subgroup analyses revealed that rs1801131 and rs1801133 polymorphisms were both significantly associated with the likelihood of glaucoma in West Asians. Nevertheless, no positive results were detected for two investigated polymorphisms in East Asians and Caucasians. The stability of synthetic results was subsequently evaluated in sensitivity analyses, and no changes of results were observed in any comparisons, which indicated that our findings were quite stable and reliable.

There are several points that need to be addressed about this meta‐analysis. Firstly, no obvious heterogeneities were detected in overall analyses for two investigated polymorphisms, which indicated that eligible studies could be considered as homogeneous, and thus synthesize the results of these studies is statistically feasible. Secondly, previous experimental studies have shown that the C to T substitution of rs1801133 (substitution of valine for alanine) and A to C substitution of rs1801131 (substitution of glutamate for alanine) could lead to reduced enzymatic activity and result in hyperhomocysteinemia, which may partially explain our positive findings (Li et al., 2017; Li, Dai, Zheng, Liu, & Huang, 2015). Thirdly, the pathogenic mechanism of glaucoma is quite complex, and hence it is unlikely that a single gene polymorphism can significantly contribute to its development. Therefore, to better illustrate potential correlations of certain gene polymorphisms with glaucoma, we strongly recommend further studies to perform haplotype analyses and explore potential gene–gene interactions.

As with all meta‐analysis, this study certainly has some limitations. First, our findings were based on unadjusted analyses due to lack of raw data, and failure to conduct further adjusted analyses for age, gender, and co‐morbidity conditions may impact the reliability of our findings (Shi, Xie, Jia, & Li, 2016; Xie, Shi, Xun, & Rao, 2017). Second, association between MTHFR polymorphisms and glaucoma may be affected by gene–gene and gene–environmental interactions. However, the majority of studies did not consider these potential interactions, which impeded us to perform relevant analyses accordingly (Xie, Shi, & Liu, 2017). Third, only retrospective case–control studies were included in this meta‐analysis, and thus direct causal relation between MTHFR polymorphisms and glaucoma could not be established (Zhao, Yin, Wang, & Si, 2015). Taken these limitations into consideration, the results of the current study should be interpreted with caution.

Overall, our meta‐analysis suggested that rs1801131 and rs1801133 polymorphisms may serve as genetic biomarkers of glaucoma in West Asians. However, further well‐designed studies are still warranted to confirm our findings.

ETHICAL APPROVAL

This article does not contain any studies with human participants or animals performed by any of the authors.

CONFLICT OF INTEREST

None declared.

AUTHORS' CONTRIBUTIONS

Ling Zhang and Bin Chen conceived of the study, participated in its design, conducted the systematic literature review, performed data analyses, and drafted the manuscript. All authors have read and approved the final manuscript.

Supporting information

 

Click here for additional data file. (499.9KB, docx)

ACKNOWLEDGMENTS

None.

Zhang L, Chen B. Correlation between MTHFR polymorphisms and glaucoma: A meta‐analysis. Mol Genet Genomic Med. 2019;7:e538 10.1002/mgg3.538

REFERENCES

  1. Al‐Shahrani, H. , Al‐Dabbagh, N. , Al‐Dohayan, N. , Arfin, M. , Al‐Asmari, M. , Rizvi, S. , & Al‐Asmari, A. (2016). Association of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism with primary glaucoma in Saudi population. BMC Ophthalmology, 16, 156 10.1186/s12886-016-0337-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Asefa, N. G. , Neustaeter, A. , Jansonius, N. M. , & Snieder, H. (2018). Heritability of glaucoma and glaucoma‐related endophenotypes: Systematic review and meta‐analysis protocol. British Medical Journal Open, 8, e019049 10.1136/bmjopen-2017-019049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Buentello‐Volante, B. , Elizondo‐Olascoaga, C. , Miranda‐Duarte, A. , Guadarrama‐Vallejo, D. , Cabral‐Macias, J. , & Zenteno, J. C. (2013). Association study of multiple gene polymorphisms with the risk of adult‐onset primary open‐angle glaucoma in a Mexican population. Experimental Eye Research, 107, 59–64. 10.1016/j.exer.2012.11.013. [DOI] [PubMed] [Google Scholar]
  4. Cissé, Y. , Bai, L. , & Meng, T. (2018). LncRNAs in genetic basis of glaucoma. BMJ Open Ophthalmology, 3, e000131 10.1136/bmjophth-2017-000131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gupta, S. , Bhaskar, P. K. , Bhardwaj, R. , Chandra, A. , Chaudhry, V. N. , Chaudhry, P. , … Mutsuddi, M. (2014). MTHFR C677T predisposes to POAG but not to PACG in a North Indian population: A case control study. PLoS ONE, 9, e103063 10.1371/journal.pone.0103063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Li, A. , Shi, Y. , Xu, L. , Zhang, Y. , Zhao, H. , Li, Q. , … He, Y. (2017). A possible synergistic effect of MTHFR C677T polymorphism on homocysteine level variations increased risk for ischemic stroke. Medicine (Baltimore)., 96, e9300 10.1097/MD.0000000000009300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Li, J. , Xu, F. , Zeng, R. , Gong, H. , & Lan, Y. (2016). Plasma homocysteine, serum folic acid, serum vitamin B12, serum vitamin B6, MTHFR, and risk of normal‐tension glaucoma. Journal of Glaucoma, 25, e94–98. 10.1097/IJG.0000000000000269. [DOI] [PubMed] [Google Scholar]
  8. Li, W. X. , Dai, S. X. , Zheng, J. J. , Liu, J. Q. , & Huang, J. F. (2015). Homocysteine Metabolism Gene Polymorphisms (MTHFR C677T, MTHFR A1298C, MTR A2756G and MTRR A66G) Jointly Elevate the Risk of Folate Deficiency. Nutrients., 7, 6670–6687. 10.3390/nu7085303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mantravadi, A. V. , & Vadhar, N. (2015). Glaucoma. Primary Care, 42, 437–449. 10.1016/j.pop.2015.05.008. [DOI] [PubMed] [Google Scholar]
  10. Moher, D. , Liberati, A. , Tetzlaff, J. , Altman, D. G. , & PRISMA group., (2009). Preferred reporting items for systematic reviews and meta‐analyses: The PRISMA statement. Annals of Internal Medicine, 151, 264–269. 10.7326/0003-4819-151-4-200908180-00135 10.7326/0003-4819-151-4-200908180-00135 10.7326/0003-4819-151-4-200908180-00135 10.7326/0003-4819-151-4-200908180-00135 [DOI] [PubMed] [Google Scholar]
  11. Nilforoushan, N. , Aghapour, S. , Raoofian, R. , Saee Rad, S. , Greene, W. K. , Fakhraie, G. , & Heidari, M. (2012). Lack of association between the C677T single nucleotide polymorphism of the MTHFR gene and glaucoma in Iranian patients. Acta Medica Iranica, 50, 208–212. [PubMed] [Google Scholar]
  12. Shi, X. , Xie, X. , Jia, Y. , & Li, S. (2016). Associations of insulin receptor and insulin receptor substrates genetic polymorphisms with polycystic ovary syndrome: A systematic review and meta‐analysis. Journal of Obstetrics and Gynaecology Research, 42, 844–854. 10.1111/jog.13002. [DOI] [PubMed] [Google Scholar]
  13. Stang, A. (2010). Critical evaluation of the Newcastle‐Ottawa scale for the assessment of the quality of nonrandomized studies in meta‐analyses. European Journal of Epidemiology, 25, 603–605. 10.1007/s10654-010-9491-z. [DOI] [PubMed] [Google Scholar]
  14. Trimmer, E. E. (2013). Methylenetetrahydrofolate reductase: Biochemical characterization and medical significance. Current Pharmaceutical Design, 19, 2574–2593. [DOI] [PubMed] [Google Scholar]
  15. Weinreb, R. N. , Aung, T. , & Medeiros, F. A. (2014). The pathophysiology and treatment of glaucoma: A review. JAMA, 311, 1901–1911. 10.1001/jama.2014.3192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wiggs, J. L. , & Pasquale, L. R. (2017). Genetics of glaucoma. Human Molecular Genetics, 26(R1), R21–R27. 10.1093/hmg/ddx184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Xie, X. , Shi, X. , & Liu, M. (2017). The roles of TLR gene polymorphisms in atherosclerosis: A systematic review and meta‐analysis of 35,317 subjects. Scandinavian Journal of Immunology, 86, 50–58. 10.1111/sji.12560. [DOI] [PubMed] [Google Scholar]
  18. Xie, X. , Shi, X. , Xun, X. , & Rao, L. (2017). Endothelial nitric oxide synthase gene single nucleotide polymorphisms and the risk of hypertension: A meta‐analysis involving 63,258 subjects. Clinical and Experimental Hypertension, 39, 175–182. 10.1080/10641963.2016.1235177. [DOI] [PubMed] [Google Scholar]
  19. Zacharaki, F. , Hadjigeorgiou, G. M. , Koliakos, G. G. , Morrison, M. A. , Tsezou, A. , Chatzoulis, D. Z. , … Tsironi, E. E. (2014). Plasma homocysteine and genetic variants of homocysteine metabolism enzymes in patients from central Greece with primary open‐angle glaucoma and pseudoexfoliation glaucoma. Clinical Ophthalmology, 8, 1819–1825. 10.2147/OPTH.S64904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Zhao, R. , Yin, D. , Wang, E. , & Si, B. (2015). The effect of MTHFR ala222val polymorphism on open‐angle glaucoma: A meta‐analysis. Ophthalmic Genetics, 36, 27–30. 10.3109/13816810.2014.969379. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

 

Click here for additional data file. (499.9KB, docx)

Articles from Molecular Genetics & Genomic Medicine are provided here courtesy of Blackwell Publishing

RESOURCES